Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Bright Minds Biosciences Inc. (DRUG) had Weighted-Average Shares Outstanding (Diluted) of 9.83M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-1.73M |
|
-- |
|
-- |
|
$8.26M |
|
$-8.26M |
|
$6.53M |
|
$-1.73M |
|
$-1.73M |
|
$-1.73M |
|
$-1.73M |
|
$-1.73M |
|
$-1.73M |
|
$-8.26M |
|
$-8.25M |
|
9.83M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
9.83M |
$-0.17 |
|
$-0.17 |
|
| Balance Sheet Financials | |
$224.12M |
|
-- |
|
$0.04M |
|
$224.16M |
|
$1.84M |
|
-- |
|
-- |
|
$1.84M |
|
$222.32M |
|
$222.32M |
|
$222.32M |
|
9.86M |
|
| Cash Flow Statement Financials | |
$-16.90M |
|
-- |
|
$174.75M |
|
$59.88M |
|
$222.34M |
|
$162.46M |
|
$2.92M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
121.97 |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-16.90M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-0.78% |
|
-0.78% |
|
-0.77% |
|
-0.78% |
|
$22.54 |
|
$-1.72 |
|
$-1.72 |
|